WO2009031144A1 - Envelope containing sterile needle - Google Patents

Envelope containing sterile needle Download PDF

Info

Publication number
WO2009031144A1
WO2009031144A1 PCT/IL2008/001192 IL2008001192W WO2009031144A1 WO 2009031144 A1 WO2009031144 A1 WO 2009031144A1 IL 2008001192 W IL2008001192 W IL 2008001192W WO 2009031144 A1 WO2009031144 A1 WO 2009031144A1
Authority
WO
WIPO (PCT)
Prior art keywords
sne
needle
distal
envelope
num
Prior art date
Application number
PCT/IL2008/001192
Other languages
French (fr)
Inventor
Zeev Bronfeld
Original Assignee
Sindolor Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sindolor Medical Ltd filed Critical Sindolor Medical Ltd
Publication of WO2009031144A1 publication Critical patent/WO2009031144A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/32Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3202Devices for protection of the needle before use, e.g. caps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M2005/3117Means preventing contamination of the medicament compartment of a syringe
    • A61M2005/3118Means preventing contamination of the medicament compartment of a syringe via the distal end of a syringe, i.e. syringe end for mounting a needle cannula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/19Constructional features of carpules, syringes or blisters
    • A61M2205/192Avoiding coring, e.g. preventing formation of particles during puncture
    • A61M2205/195Avoiding coring, e.g. preventing formation of particles during puncture by the needle tip shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/19Constructional features of carpules, syringes or blisters
    • A61M2205/192Avoiding coring, e.g. preventing formation of particles during puncture
    • A61M2205/197Avoiding coring, e.g. preventing formation of particles during puncture by the seal material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/20Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/32Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3287Accessories for bringing the needle into the body; Automatic needle insertion

Definitions

  • Rebiject and Rebiject II autoinjectors for Rebif the drug for interferon beta- Ia used to treat Multiple Sclerosis.
  • Other autoinjectors exist for diabetics.
  • a long felt need exists for an easily fitted sterile needle suitably packaged for an autoinjector which, when presented to the body of the patient for injection, pierces the patient whilst maintaining it's sterility up to the moment of penetration.
  • a surprising object of the invention is to provide a sterile needle envelope (SNE) enclosing a sharp ended needle wherein the r ⁇ edle is adapted' and disposed to pierce the envelope whilst the needle is penetrating the body of the patient.
  • SNE sterile needle envelope
  • Another object of the invention is to disclose an SNE as defined above, further
  • Another object of the invention is to provide an SNE as defined above, wherein the envelope is made at least in part from an essentially flexible material.
  • the material is selected from the group consisting of rubber, latex, plastic, synthetic material, metal, glass, glass-like material, plexiglass, rubber, rubber-like material and any composition thereof.
  • Another object of the invention is to provide an SNE as defined above, wherein the SNE further comprises means for connecting the needle to an external needle urging means
  • Another object of the invention is to provide an SNE as defined above, wherein the SNE further comprises means for directly connecting said needle to external reciprocating needle injecting means.
  • Another object of the invention is to provide an SNE as defined above, wherein the SNE further comprises means for indirectly connecting said needle to external reciprocating needle injecting means.
  • Another object * of the invention is to provide an SNE as defined above, wherein at least a section of a distal portion of the SNE is at least one of the following: frangible, perforatable, and pierceable.
  • Another object of the invention is to provide an SNE as defined above, wherein the section is frangible, perforatable and pierceable in a predetermined manner.
  • Another objective of the invention is to provide an SNE as defined above, wherein a distal end of the needle is adapted so as to prevent blocking by envelope fragments and debris during piercing of the SNE by the needle.
  • a yet further object of the invention is to provide an SNE as defined above, wherein said
  • NUM is part of an autoinjector.
  • a still further object of the invention is to provide an SNE as defined above wherein said
  • a still further object of the invention is to provide an SNE as defined above wherein the
  • NUM is part of a syrette.
  • a further object of the invention is to provide an SNE as defined above wherein the NUM is part of a standard hypodermic syringe.
  • FIG. 1 is a schematic block diagram illustration of an syringe device comprising a needle that is sealingly enclosed by a sterile needle envelope, according to some embodiments of the invention; ⁇ • ⁇ ⁇
  • FIG. 2B is another schematic block diagram illustration of the syringe device, wherein the distal end of the sterile needle envelope is being perforated by the distal needle edge, according to some embodiments of the invention
  • the needle is adapted and disposed to pierce the envelope whilst the needle is penetrating the body of the patient.
  • the SNE comprises means for connecting the needle to an external liquid reservoir (ELR).
  • ELR external liquid reservoir
  • a further disclosure is made of an SNE as defined above, wherein the SNE further comprises means for connecting the needle to an external needle urging means (NUM).
  • NUM an external needle urging means
  • SNE as defined above, wherein the SNE further comprises means for connecting the needle to an.external reciprocating needle injecting means.
  • SNE as defined above, wherein at least a section of a distal portion of the SNE is characterized by at least one of the following: frangible, perforatable, and pierceable.
  • autoinjector refers to a device designed to deliver a single dose of a particular drug, often by self administration.
  • the SNE is configured to be . fitted to an injection device such as an autoinjector, syrette or hypodermic syringe.
  • the envelope may be frangible and/or perforatable by the needle.
  • the needle may be suitably engaged with the patient's skin and the needle may be urged into the body.
  • a syringe device 100 may include- an external liquid reservoir (ELR) 110 having an opening
  • ELR 110 is configured to securely contain therein substances such as, for example, and insulin.
  • ELR 110 may further include means and/or may be configured to enable varying the volumetric capacity -of ELR llO.F ⁇ r example, ELR 110, may be .embodied by a receptacle wherein means that enable varying the receptacle's volumetric capacity may include a plunger (e.g., plunger 120) that is slidably coupled within the receptacle, whereby the plunger may be configured such to abut against the inner wall of the receptacle.
  • plunger 120 provides a substantially sealed seal. It should be noted that the term "substantially sealed seal" includes “sealed"seal”.
  • Syringe device 100 further includes a sharp ended needle (hereinafter referred to as "needle") 130, e.g., as known in the art, comprising a bore (not shown).
  • the bore may have a diameter of, for example, about 0.1mm to about 0.3 mm
  • Other embodiments of the invention may have needle bores of about 10 microns to about 500 microns.
  • Needle 130 is mechanically coupled to ELR 110 such that a proximate opening 132 of the bore of needle 130 is positioned relative to outlet 111 of ELR 110.
  • the mechanical coupling may be substantially sealed or sealed.
  • ELR 110 in association with needle 130 and the corresponding mechanical coupling constitute a sealed cavity having one opening, which is the distal opening 131 of the bore of needle 130.
  • an increase in the volumetric capacity of ELR 110 generates a vacuum at distal opening 131, thereby enabling suction of a substance into ELR 110.
  • a decrease in the volumetric capacity of ELR 110 causes the ejection of the substance from ELR 110 through distal opening 131.
  • the mechanical coupling of needle 130 to ELR 110 may be embodied, for example, by integrally forming needle 130 with ELR 110.
  • SNE 140 comprises means, e.g., as known in the art, for connecting needle 130 to ELR 110.
  • needle 130 may be mechanically coupled to ELR 110 by means of a Luer Lock.
  • Needle 130 may be embodied, for example, by an anti-coring needle (e.g., a Tuohy needle); hypodermic needles and other needles, e.g., as known in the art. Further, needle 130 may have a distal needle edge 133, which may have various shapes.
  • Distal needle edge 133 may be, for example, a sharp pointed tip embodied, for example, by a standard bevel, by a short bevel or by a true short bevel, e.g., as known in the art. Further, needle 130 may be configured to enable intermuscular injection, subcutaneous injection or other injection types.
  • syringe device 100 may include a sterile needle envelope (SNE) 140, which sealingly encloses at least the portion of needle 130 that may be engaged with' substance transfer site 160.
  • SNE sterile needle envelope
  • SNE 140 may sealingly enclose all of needle 130, and in some embodiments of the invention, SNE 140 may sealingly enclose needle 130 as well as other elements of syringe device 100 such as, for example, ELR 110.
  • ELR 110 elements of syringe device 100
  • the above-mentioned embodiments are hereinafter referred to by the term “sealingly enclosing" and by grammatical variations thereof.
  • SNE 140 may have distal SNE end 141 that is positioned in front of distal opening 131, whereby SNE 140 may be made of any suitable packaging material, e.g., as known in the art, such as, , for example, synthetic material (e.g., plastic, latex), metal, glass or glass-like material (e.g., plexiglass), rubber or rubber-like material or any composition thereof.
  • suitable packaging material e.g., as known in the art, such as, , for example, synthetic material (e.g., plastic, latex), metal, glass or glass-like material (e.g., plexiglass), rubber or rubber-like material or any composition thereof.
  • Needle 130 as well as at least the inner side of SNE 140 that sealingly encloses needle 130 may be sterile or substantially sterile.
  • sterile needle envelope and grammatical variations thereof as used herein may refer to any type of covering, layer, coating, envelop, wrapping, enclosure, sleeve, shell or membrane adapted to protect needle 130 from contamination or substantial contamination.
  • distal opening 131 of needle 130 is adapted so as to prevent blocking by envelope fragments and debris during piercing and/or perforation and/or fraction Of SNE 140 by needle 130:-
  • syringe device 100 is adapted or includes a needle urging means (NUM) causing a relative longitudinal displacement of distal -needle edge 133 against distal SNE end 141, -when operation of syringe 100 is initiated by, e.g., a user of syringe device 100.
  • NUM needle urging means
  • distal edge 131 may perforate or fracture distal SNE end 141.
  • SNE 140 may is adapted to be connected to reciprocating needle injecting means
  • needle 130 may be operatively coupled to plunger 120 in a manner such that longitudinal displacement of plunger 120 (which is schematically illustrated with arrow Q) results in a longitudinal displacement of distal needle edge 133 towards distal SNE end 141.
  • Longitudinal displacement of distal needle edge 133 towards distal SNE end 141 may be accomplished, for example, by telescopically lengthening needle 130; by longitudinally displacing needle 130 towards distal SNE end 141 or by other suitable NUM.
  • the longitudinal displacement causes the engagement of distal needle edge 133 with distal SNE end 141, whereby distal needle edge 133 and/or distal SNE end 141 may be configured such that said engagement results in a perforation of distal SNE end 141.
  • the perforation may be a result of pressure applied by distal needle edge 133 against distal SNE end 141, whereby the pressure causes tearing of distal SNE end 141.
  • the perforation may be a result of an incision operation performed by distal needle edge 133 during its engagement with distal SNE end 141.
  • distal needle edge 133 may have a beveled tip that extends towards cutting edges terminating in the wall of needle 130.
  • distal needle edge 133 During engagement of distal needle edge 133 with distal SNE end 141, the beveled tip punches a hole in distal SNE end 141, whereby ongoing longitudinal displacement causes the 1 cutting edges to cut out and/or perform an incision in distal SNE end 141.
  • traversing of at least some portion of needle 130 towards fluid transfer site 160 is enabled, as is schematically illustrated in FIG. 2B.
  • distal SNE end 141 may be configured to facilitate its perforation by, e.g., distal needle edge 133.
  • distal SNE end 141 may have a pierced boundary; or may have a weakened boundary.
  • distal needle edge 133 and/or distal SNE end 141 may be configured to avoid insertion and/or clogging of the bore of needle 130 by material of SNE 140.
  • Syringe device 100 is configured and/or adapted such suitable operation thereof causes longitudinal displacement of distal needle edge 133 towards injection site 160, as well as insertion of needle 130 into injection site 160.
  • needle 130 may engage with the substance transfer site by, e.g., hypodermically introducing the needle into the body.
  • operation of the syringe device may be initiated for, e.g., withdrawing a substance from the body, into the syringe device and/or, e.g., for transferring substance from the syringe into the body.
  • syringe device 100 may be embodied by, for example, a patient, healthcare personnel (e.g., a nurse, a physician) and the like.
  • syringe device may be embodied by mechanisms as known in the art and/or by syringe devices that are not yet known in the art.
  • SNE 140 enclosing needle 130 is adapted and/or disposed alone to pierce the SNE when needle 130 is penetrating a body via, e.g., liquid transfer site 160.
  • NUM may be a part of an automjector and/or a needle cartridge.

Abstract

A sterile needle envelope (SNE) (140) enclosing a sharp ended needle (130) is disclosed. The aforementioned needle is adapted and disposed to pierce the envelope whilst the needle is penetrating the body of the patient.

Description

ENVELOPE CONTAINING STERILE NEEDLE
FIELD OF THE INVENTION
[001] The present invention relates to the field of syringe needles and devices. More specifically, the present invention relates to packaging of syringe needles for home, field and high patient throughput use. BACKGROUND OF THE INVENTION
Many chronic sufferers of disease such as diabetes are medically obliged to self inject therapeutic preparations.-The traditional hypodermic syringe is difficult to use by non medical operators. Devices and methods have been developed to 'de-skill" the operation of self injection by means of auto injectors. Most auto injectors are spring-loaded syringes. By design, autoinjectors are intended for self-administration by patients. The site of injection depends on the drug loaded, but it typically is administered into the thigh or the buttocks. The injectors were initially designed to overcome the hesitation associated with self-administration of needle-based drugs. Examples include EpiPens, or the recently introduced Twinject, which is often prescribed to people who are at risk for anaphylaxis. Rebiject and Rebiject II autoinjectors for Rebif, the drug for interferon beta- Ia used to treat Multiple Sclerosis. Other autoinjectors exist for diabetics. With the population aging, and more and more relatively infirm people needing to self - inject drugs, a long felt need exists for making these operations easy and safe. A long felt need exists for an easily fitted sterile needle suitably packaged for an autoinjector which, when presented to the body of the patient for injection, pierces the patient whilst maintaining it's sterility up to the moment of penetration. SUMMARY OF THE INVENTION
A surprising object of the invention is to provide a sterile needle envelope (SNE) enclosing a sharp ended needle wherein the røedle is adapted' and disposed to pierce the envelope whilst the needle is penetrating the body of the patient.
Moreover, another object of the invention is to disclose an SNE as defined above, further
'wherein the SNE further comprises means for- connecting the needle to an external liquid reservoir (ELR).
Another object of the invention is to provide an SNE as defined above, wherein the envelope is made at least in part from an essentially flexible material. The material is selected from the group consisting of rubber, latex, plastic, synthetic material, metal, glass, glass-like material, plexiglass, rubber, rubber-like material and any composition thereof.
Another object of the invention is to provide an SNE as defined above, wherein the SNE further comprises means for connecting the needle to an external needle urging means
(NUM).
Another object of the invention is to provide an SNE as defined above, wherein the SNE further comprises means for directly connecting said needle to external reciprocating needle injecting means.
Another object of the invention is to provide an SNE as defined above, wherein the SNE further comprises means for indirectly connecting said needle to external reciprocating needle injecting means.
Another object of the invention is to provide an SNE as defined above, wherein the needle has a bore of about 0.1mm. to about 0.3 mm. Another object of the invention is to provide an SNE as defined above, wherein the needle has a bore of aboutlO microns to about 500 microns
Another object* of the invention is to provide an SNE as defined above, wherein at least a section of a distal portion of the SNE is at least one of the following: frangible, perforatable, and pierceable.
Another object of the invention is to provide an SNE as defined above, wherein the section is frangible, perforatable and pierceable in a predetermined manner.
Another objective of the invention is to provide an SNE as defined above, wherein a distal end of the needle is adapted so as to prevent blocking by envelope fragments and debris during piercing of the SNE by the needle.
A yet further object of the invention is to provide an SNE as defined above, wherein said
NUM is part of an autoinjector.
A still further object of the invention is to provide an SNE as defined above wherein said
NUM is part of a needle cartridge.
A still further object of the invention is to provide an SNE as defined above wherein the
NUM is part of a syrette.
Lastly, a further object of the invention is to provide an SNE as defined above wherein the NUM is part of a standard hypodermic syringe.
BRIEF DESCRIPTION OF THE FIGURES
[002] The subject matter regarded as the invention will become more clearly understood in light of the ensuing description of embodiments thereof, given by way of example only, with reference to the accompanying figures (FIGs), wherein [003] FIG. 1 is a schematic block diagram illustration of an syringe device comprising a needle that is sealingly enclosed by a sterile needle envelope, according to some embodiments of the invention; ■ • < ■
[004] FIG. 2A is a schematic block diagram illustration of the syringe device, wherein a distal needle edge thereof engages with a distal end of the sterile needle envelope, according to some embodiments of the invention;
[005] FIG. 2B is another schematic block diagram illustration of the syringe device, wherein the distal end of the sterile needle envelope is being perforated by the distal needle edge, according to some embodiments of the invention;
[006] FIG. 3 is a -schematic block diagram illustration of administration of substance to an syringe site via the needle, according to some embodiments of the invention; and
[007] The figures taken with description make apparent to those skilled in the art how the invention may be embodied in practice.
[008] It will be appreciated that for simplicity and clarity of illustration, elements shown in the figures have not necessarily been drawn to scale. For example, the dimensions of some of the elements may be exaggerated relative to other elements for clarity. Further, where considered appropriate, reference numerals may be repeated among the figures to indicate corresponding or analogous elements.
DETAILED DESCRIPTION OF THE INVENTION
The invention discloses a sterile needle envelope (SNE) enclosing a sharp ended needle.
The needle is adapted and disposed to pierce the envelope whilst the needle is penetrating the body of the patient. Reference is made to a further disclosure such that the SNE comprises means for connecting the needle to an external liquid reservoir (ELR).
A further disclosure is made of an SNE as defined above, wherein the envelope is made at least in part from an essentially flexible material. The material is selected from the group consisting of rubber, latex, plastic, synthetic material, metal, glass, glass-like material, plexiglass, rubber, rubber-like material and any composition thereof.
A further disclosure is made of an SNE as defined above, wherein the SNE further comprises means for connecting the needle to an external needle urging means (NUM).
Reference is now made to an SNE as defined above, wherein the SNE further comprises means for connecting the needle to an.external reciprocating needle injecting means.
Reference is now made to an SNE as defined above, wherein the needle has a bore of about 0.1mm. to about 0.3 mm.
Reference is further made to an SNE as defined above, wherein the needle has a bore of about 10 microns to about 500 microns.
Reference is again made to an SNE as defined above, wherein at least a section of a distal portion of the SNE is characterized by at least one of the following: frangible, perforatable, and pierceable.
Reference is now made to an SNE as defined above, wherein at least a section of a distal portion of the SNE is frangible, perforatable and pierceable in a predetermined manner.
Reference is now made to an SNE as defined above, wherein a distal end of the needle is adapted so as to prevent blocking by envelope fragments and debris during the piercing of the SNE by the needle. Moreover reference is further made to the SNE as defined above, wherein the NUM is part of an autoinjector.
Yet further reference is made to the SNE as defined above, wherein the NUM is part of a needle cartridge.
Reference is yet further made to the SNE as defined above, wherein the NUM is part of a syrette.
Lastly, reference is made to the SNE as defined above, wherein the NUM is part of a standard hypodermic syringe.
The term "autoinjector" herein refers to a device designed to deliver a single dose of a particular drug, often by self administration.
The present invention discloses a sterile needle envelope (SNE). The SNE encloses a hypodermic needle, in order to minimize the risk of contamination of the needle prior to its engagement with the patient's skin.
[Q09] In some embodiments of the invention, the SNE is configured to be . fitted to an injection device such as an autoinjector, syrette or hypodermic syringe. The envelope may be frangible and/or perforatable by the needle.
[0010] Instantaneously after the perforation of the SNE, the needle may be suitably engaged with the patient's skin and the needle may be urged into the body.
[0011] Reference is now made to FIG. 1. According to some embodiments of the invention, a syringe device 100 may include- an external liquid reservoir (ELR) 110 having an opening
111, whereby ELR 110 is configured to securely contain therein substances such as, for example, and insulin. ELR 110 may further include means and/or may be configured to enable varying the volumetric capacity -of ELR llO.Før example, ELR 110,,may be .embodied by a receptacle wherein means that enable varying the receptacle's volumetric capacity may include a plunger (e.g., plunger 120) that is slidably coupled within the receptacle, whereby the plunger may be configured such to abut against the inner wall of the receptacle. Thusly, plunger 120 provides a substantially sealed seal. It should be noted that the term "substantially sealed seal" includes "sealed"seal".
[0012] Syringe device 100 further includes a sharp ended needle (hereinafter referred to as "needle") 130, e.g., as known in the art, comprising a bore (not shown). The bore may have a diameter of, for example, about 0.1mm to about 0.3 mm Other embodiments of the invention may have needle bores of about 10 microns to about 500 microns. Needle 130 is mechanically coupled to ELR 110 such that a proximate opening 132 of the bore of needle 130 is positioned relative to outlet 111 of ELR 110. The mechanical coupling may be substantially sealed or sealed. Correspondingly, ELR 110 in association with needle 130 and the corresponding mechanical coupling constitute a sealed cavity having one opening, which is the distal opening 131 of the bore of needle 130. Thusly configured, an increase in the volumetric capacity of ELR 110 generates a vacuum at distal opening 131, thereby enabling suction of a substance into ELR 110. Conversely, a decrease in the volumetric capacity of ELR 110 causes the ejection of the substance from ELR 110 through distal opening 131. [0013] It should be noted that in some embodiments of the invention, the mechanical coupling of needle 130 to ELR 110 may be embodied, for example, by integrally forming needle 130 with ELR 110. In some additional or alternative embodiments of the invention, SNE 140 comprises means, e.g., as known in the art, for connecting needle 130 to ELR 110. For example, needle 130 may be mechanically coupled to ELR 110 by means of a Luer Lock. [0014] Needle 130 may be embodied, for example, by an anti-coring needle (e.g., a Tuohy needle); hypodermic needles and other needles, e.g., as known in the art. Further, needle 130 may have a distal needle edge 133, which may have various shapes. Distal needle edge 133 may be, for example, a sharp pointed tip embodied, for example, by a standard bevel, by a short bevel or by a true short bevel, e.g., as known in the art. Further, needle 130 may be configured to enable intermuscular injection, subcutaneous injection or other injection types. [0015] According to some embodiments of the invention, syringe device 100 may include a sterile needle envelope (SNE) 140, which sealingly encloses at least the portion of needle 130 that may be engaged with' substance transfer site 160. However; in some embodiments Of "the invention, SNE 140 may sealingly enclose all of needle 130, and in some embodiments of the invention, SNE 140 may sealingly enclose needle 130 as well as other elements of syringe device 100 such as, for example, ELR 110. For exemplary and simplifying purposes only, the above-mentioned embodiments are hereinafter referred to by the term "sealingly enclosing" and by grammatical variations thereof.
[001"6] SNE 140 may have distal SNE end 141 that is positioned in front of distal opening 131, whereby SNE 140 may be made of any suitable packaging material, e.g., as known in the art, such as, , for example, synthetic material (e.g., plastic, latex), metal, glass or glass-like material (e.g., plexiglass), rubber or rubber-like material or any composition thereof. [0017] Needle 130 as well as at least the inner side of SNE 140 that sealingly encloses needle 130, may be sterile or substantially sterile.
[0018] It should be noted that the sterile needle envelope and grammatical variations thereof as used herein may refer to any type of covering, layer, coating, envelop, wrapping, enclosure, sleeve, shell or membrane adapted to protect needle 130 from contamination or substantial contamination. [0019] In some embodiments of the invention, distal opening 131 of needle 130 is adapted so as to prevent blocking by envelope fragments and debris during piercing and/or perforation and/or fraction Of SNE 140 by needle 130:-
[0020] Reference is now made to FIG. 2A and to FIG. 2B. In some embodiments of the invention, syringe device 100 is adapted or includes a needle urging means (NUM) causing a relative longitudinal displacement of distal -needle edge 133 against distal SNE end 141, -when operation of syringe 100 is initiated by, e.g., a user of syringe device 100. As a result, of said longitudinal displacement, distal edge 131 may perforate or fracture distal SNE end 141. Correspondingly, SNE 140 may is adapted to be connected to reciprocating needle injecting means For .example, in .some embodiments of the invention, needle 130 may be operatively coupled to plunger 120 in a manner such that longitudinal displacement of plunger 120 (which is schematically illustrated with arrow Q) results in a longitudinal displacement of distal needle edge 133 towards distal SNE end 141. Longitudinal displacement of distal needle edge 133 towards distal SNE end 141 may be accomplished, for example, by telescopically lengthening needle 130; by longitudinally displacing needle 130 towards distal SNE end 141 or by other suitable NUM. The longitudinal displacement causes the engagement of distal needle edge 133 with distal SNE end 141, whereby distal needle edge 133 and/or distal SNE end 141 may be configured such that said engagement results in a perforation of distal SNE end 141. For example, in some embodiments of the invention, the perforation may be a result of pressure applied by distal needle edge 133 against distal SNE end 141, whereby the pressure causes tearing of distal SNE end 141. Additionally or alternatively, the perforation may be a result of an incision operation performed by distal needle edge 133 during its engagement with distal SNE end 141. For example, distal needle edge 133 may have a beveled tip that extends towards cutting edges terminating in the wall of needle 130. During engagement of distal needle edge 133 with distal SNE end 141, the beveled tip punches a hole in distal SNE end 141, whereby ongoing longitudinal displacement causes the1 cutting edges to cut out and/or perform an incision in distal SNE end 141. As a result, traversing of at least some portion of needle 130 towards fluid transfer site 160 is enabled, as is schematically illustrated in FIG. 2B.
[0021] In some embodiments of the invention, distal SNE end 141 may be configured to facilitate its perforation by, e.g., distal needle edge 133. For example, distal SNE end 141 may have a pierced boundary; or may have a weakened boundary.
[0022] It should be noted that in some embodiments of the invention, distal needle edge 133 and/or distal SNE end 141 may be configured to avoid insertion and/or clogging of the bore of needle 130 by material of SNE 140.
[0023] Reference is now made to FIG. 3. Syringe device 100 is configured and/or adapted such suitable operation thereof causes longitudinal displacement of distal needle edge 133 towards injection site 160, as well as insertion of needle 130 into injection site 160. Correspondingly, instantaneously after the perforation of distal SNE end 141, needle 130 may engage with the substance transfer site by, e.g., hypodermically introducing the needle into the body. After suitable engagement of the needle with the substance transfer site, operation of the syringe device may be initiated for, e.g., withdrawing a substance from the body, into the syringe device and/or, e.g., for transferring substance from the syringe into the body. [0024] It should be noted that the user of syringe device 100 may be embodied by, for example, a patient, healthcare personnel (e.g., a nurse, a physician) and the like. [0025] It should be noted that the syringe device may be embodied by mechanisms as known in the art and/or by syringe devices that are not yet known in the art.
[0026] According to some embodiments of the invention, SNE 140 enclosing needle 130 is adapted and/or disposed alone to pierce the SNE when needle 130 is penetrating a body via, e.g., liquid transfer site 160.
[0027] In some embodiments of the invention, NUM may be a part of an automjector and/or a needle cartridge.
[0028] While the invention has been described with respect to a limited number of embodiments, these should not be construed as limitations on the scope of the invention, but rather as exemplifications of some of the embodiments. Those skilled in the art will envision other possible variations, modifications, and programs that are also within the scope of the invention. Accordingly, the scope of the invention should not be limited by what has thus far been described, but by the appended claims and their legal equivalents. Therefore, it is to be understood that alternatives, modifications, and variations of the present invention are to be construed as being within the scope and spirit of the appended claims.

Claims

CLAIMSWhat is claimed is:
1. A sterile1 needle envelope (SNE) enclosing a sharp ended needle wherein said needle is adapted and disposed to pierce said envelope whilst said needle is penetrating the body of the patient.
2. The SNE according to claim 1, further wherein said SNE further comprises means for directly connecting said needle to an external liquid reservoir (ELR).
3. The SNE according to claim 1, further wherein said SNE further comprises means for indirectly connecting said needle to an external liquid reservoir (ELR).
4. The SNE according to claim 1 wherein said envelope is made at least in part from an essentially flexible material, said material selected from the group consisting of rubber, latex, plastic, synthetic material, metal, glass, glass-like material, plexiglass, rubber, rubber-like material and any composition thereof.
5. The SNE according to claim 1, wherein said SNE further comprises means for directly connecting said needle to external needle urging means (NUM).
6. The SNE according to claim 1, wherein said SNE further comprises means for directly connecting said needle to external needle urging means (NUM).
7. The SNE according to claim 1, wherein said SNE further comprises means for connecting said needle to external reciprocating needle injecting means.
8. The SNE according to' "claim" I; wherein said needle has a bore1 of about 0.1mm. to about 0.3 mm.
9. The SNE according to claim 1, wherein said needle has a bore of about 10 microns to about 500 microns
10. The SNE according to claim 1, wherein at least a section of a distal portion of said SNE is at least one of the following: frangible, perforatable, and pierceable.
11. The SNE according to claim - 10, wherein, said section is frangible, perforatable and pierceable in a predetermined manner.
12. . The SNE according to claim 1, wherein a distal end of said needle is adapted so as to prevent blocking by envelope fragments and debris during said piercing of said SNE by said needle.
13. . The SNE of claim5, wherein said NUM is part of an autoinjector.
14. The SNE of claim 5, wherein said NUM is part of a needle cartridge.
15. The SNE of claim 5, wherein said NUM is part of a standard hypodermic syringe.
Ϊ3
PCT/IL2008/001192 2007-09-05 2008-09-04 Envelope containing sterile needle WO2009031144A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL185741A IL185741A0 (en) 2007-09-05 2007-09-05 Envelope containing sterile needle
IL185741 2007-09-05

Publications (1)

Publication Number Publication Date
WO2009031144A1 true WO2009031144A1 (en) 2009-03-12

Family

ID=39942407

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2008/001192 WO2009031144A1 (en) 2007-09-05 2008-09-04 Envelope containing sterile needle

Country Status (2)

Country Link
IL (1) IL185741A0 (en)
WO (1) WO2009031144A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9682222B2 (en) 2013-05-31 2017-06-20 3M Innovative Properties Company Microneedle injection apparatus comprising an inverted actuator
US9872975B2 (en) 2013-05-31 2018-01-23 3M Innovative Properties Company Microneedle injection and infusion apparatus and method of using same
US9895520B2 (en) 2013-05-31 2018-02-20 3M Innovative Properties Company Microneedle injection apparatus comprising a dual cover
WO2022033783A1 (en) 2020-08-13 2022-02-17 Novo Nordisk A/S Coated needle cannula
WO2022175256A1 (en) 2021-02-16 2022-08-25 Novo Nordisk A/S Hypodermic needle with sealing feature

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0288443A1 (en) * 1987-04-14 1988-10-26 Astra Meditec AB Automatic two-chamber injector, method for mixing and injecting, and injector cartridge
US5685256A (en) * 1995-01-20 1997-11-11 Gas Research Institute Set pressure sensing and verifying device
US5885255A (en) * 1994-12-20 1999-03-23 Jaeger, Jr.; Cletus Wilfred Protective needle cover
DE19856167C1 (en) * 1998-12-05 2000-05-04 Vetter & Co Apotheker Needle protection for e.g. syringes includes protective casing inside protective cap which remains in place during self-injection, to help assure hygiene and to hide the needle
WO2006083876A2 (en) * 2005-02-01 2006-08-10 Intelliject, Llc Devices, systems, and methods for medicament delivery

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0288443A1 (en) * 1987-04-14 1988-10-26 Astra Meditec AB Automatic two-chamber injector, method for mixing and injecting, and injector cartridge
US5885255A (en) * 1994-12-20 1999-03-23 Jaeger, Jr.; Cletus Wilfred Protective needle cover
US5685256A (en) * 1995-01-20 1997-11-11 Gas Research Institute Set pressure sensing and verifying device
DE19856167C1 (en) * 1998-12-05 2000-05-04 Vetter & Co Apotheker Needle protection for e.g. syringes includes protective casing inside protective cap which remains in place during self-injection, to help assure hygiene and to hide the needle
WO2006083876A2 (en) * 2005-02-01 2006-08-10 Intelliject, Llc Devices, systems, and methods for medicament delivery

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9682222B2 (en) 2013-05-31 2017-06-20 3M Innovative Properties Company Microneedle injection apparatus comprising an inverted actuator
US9872975B2 (en) 2013-05-31 2018-01-23 3M Innovative Properties Company Microneedle injection and infusion apparatus and method of using same
US9895520B2 (en) 2013-05-31 2018-02-20 3M Innovative Properties Company Microneedle injection apparatus comprising a dual cover
US10391290B2 (en) 2013-05-31 2019-08-27 3M Innovative Properties Company Microneedle injection apparatus comprising a dual cover
US10695547B2 (en) 2013-05-31 2020-06-30 3M Innovative Properties Company Microneedle injection apparatus comprising an inverted actuator
US10716926B2 (en) 2013-05-31 2020-07-21 Kindeva Drug Delivery L.P. Microneedle injection and infusion apparatus and method of using same
US11771878B2 (en) 2013-05-31 2023-10-03 Kindeva Drug Delivery L.P. Microneedle injection and infusion apparatus and method of using same
WO2022033783A1 (en) 2020-08-13 2022-02-17 Novo Nordisk A/S Coated needle cannula
WO2022175256A1 (en) 2021-02-16 2022-08-25 Novo Nordisk A/S Hypodermic needle with sealing feature

Also Published As

Publication number Publication date
IL185741A0 (en) 2008-01-06

Similar Documents

Publication Publication Date Title
US10166346B2 (en) Bruiseless cannula
JP2008522754A (en) Retrofit type fixed needle syringe and automatic injection apparatus having the same
MX2007011239A (en) Filling system and method for syringes with short needles.
CZ284097B6 (en) Syringe
JP2013514113A (en) Syringe
US8454564B2 (en) Applicator and method for applying lock solution in a catheter
WO2009031144A1 (en) Envelope containing sterile needle
US20080119797A1 (en) System with a syringe device and a needle device
US20230133017A1 (en) Connector for Aseptic Transfer of Fluid
EP1514565A1 (en) Sequential impulse / Delivery fluid medicament injector
AU2011261226A1 (en) Systems and methods for a medical syringe
JP2011510719A (en) A system that injects fluid through or into the human skin
US8439891B1 (en) IV start device and method
EP1575646A2 (en) Infusion apparatus for infusion bags
CN111032126B (en) Multiple use drug delivery device for drugs with less preservative
WO2001052925A1 (en) Pen needle assembly and adapter
CN217187468U (en) Implanted local drug delivery device
RU2289427C1 (en) Disposable apparatus for injection of medicinal preparation &#34;aers&#34;
KR20070062002A (en) Needle for dental treatment
US20210260275A1 (en) Multi-use drug delivery device for drugs with insufficinet level of preservatives
WO2019235637A2 (en) Syringe having movable syringe needle and camouflage pain point needle
JPH0131908B2 (en)
RU160804U1 (en) DEVICE FOR ADMINISTRATION OF MEDICINES
WO2022251089A1 (en) Combined biological sampling and injection assemblies and associated devices, systems, and methods
GB2388032A (en) Medical Agent Delivery

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08789863

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08789863

Country of ref document: EP

Kind code of ref document: A1